Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective

Annals of Medicine and Surgery

Volumn 3, Issue 3, 2014, Pages 85-91

  Kurup, Asok ^a   Liau, Kui Hin ^b   Ren, Jianan ^c   Lu, Min Chi ^d,e   Navarro, Narciso S ^f   Farooka, Muhammad Waris ^g   Usman, Nurhayat ^h   Destura, Raul V ⁱ   Sirichindakul, Boonchoo ^j   Tantawichien, Terapong ^k   Lee, Christopher K C ^g   Solomkin, Joseph S ^l  

^a MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^b Nexus Surgical Associates Pte Ltd Mount Elizabeth Novena Specialist Centre   (Singapore)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f UNIVERSITY OF SANTO TOMAS   (Philippines)

^g Department of Surgery Service Institute of Medical Sciences ^*  (Malaysia)

^h Hasan Sadikin Hospital   (Indonesia)

ⁱ UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^j KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^k CHULALONGKORN UNIVERSITY   (Thailand)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Antibiotics; Asia; Epidemiology; Intra abdominal infection; Microbiology; Resistance

Indexed keywords

ALBENDAZOLE; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; DORIPENEM; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEBENDAZOLE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; TINIDAZOLE; UNINDEXED DRUG; VANCOMYCIN; CARBAPENEMASE; CEPHALOSPORIN; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE; METALLO BETA LACTAMASE; PENICILLINASE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; AMEBIC INFECTION; ANTIBIOTIC RESISTANCE; ASCARIASIS; CHOLANGITIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; HUMAN; MICROBIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; TROPICAL DISEASE; ABDOMINAL TUBERCULOSIS; AEROMONAS HYDROPHILA; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CITROBACTER FREUNDII; COMMUNITY ACQUIRED INFECTION; ENTEROBACTER CLOACAE; HEALTHCARE ASSOCIATED INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PROTEUS MIRABILIS; SALMONELLOSIS; STAPHYLOCOCCUS HAEMOLYTICUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84908461927     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amsu.2014.06.005     Document Type: Review

References (38)

1. Solomkin J.S., Mazuski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
2. Sartelli M., Viale P., Catena F., Ansaloni L., Moore E., Malangoni M., et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2013, 8:3.
3. Hsueh P.R., Hawkey P.M. Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. Int J Antimicrob Agents 2007, 30:129-133.
4. Chow J.W., Satishchandran V., Snyder T.A., Harvey C.M., Friedland I.R., Dinubile M.J. Invitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2005, 6:439-448.
5. Baquero F., Hsueh P.R., Paterson D.L., Rossi F., Bochicchio G.V., Gallagher G., et al. Invitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2009, 10:99-104.
6. Chen W.Y., Jang T.N., Huang C.H., Hsueh P.R. Invitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. JMicrobiol Immunol Infect 2009, 42:317-323.
7. Yang Q., Wang H., Chen M., Ni Y., Yu Y., Hu B., et al. Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2010, 36:507-512.
8. Chen Y.H., Hsueh P.R., Badal R.E., Hawser S.P., Hoban D.J., Bouchillon S.K., et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. JInfect 2011, 62:280-291.
9. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E. Invitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 2009, 34:585-588.
10. Hsueh P.R. Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010. Int J Antimicrob Agents 2012, 40(Suppl.):S1-S3.
11. Tan T.Y., Hsu L.Y., Koh T.H., Ng L.S., Tee N.W., Krishnan P., et al. Antibiotic resistance in Gram-negative bacilli: a Singapore perspective. Ann Acad Med Singap 2008, 37:819-825.
12. Liew Y.X., Krishnan P., Yeo C.L., Tan T.Y., Lee S.Y., Lim W.P., et al. Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study. PLoS One 2011, 6(12):e28751.
13. National Antimicrobial Resistance Surveillance Center Thailand. Prevalence of pathogens recovered from abdominal/ascites fluid in Thailand in 2009. Available from: . [accessed 25.06.13]. http://narst.dmsc.moph.go.th/a5.php.
14. Lee Y.L., Chen Y.S., Toh H.S., Huang C.C., Liu Y.M., Ho C.M., et al. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010. Int J Antimicrob Agents 2012, 40(Suppl.1):S29-S36.
15. Hawser S.P., Badal R.E., Bouchillon S.K., Hoban D.J. Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008. JMed Microbiol 2010, 59:1050-1054. The SMART India Working Group.
16. Salvador V.B., Lozada M.C., Consunji R.J. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center. Surg Infect (Larchmt) 2011, 12:105-111.
17. Goo J.C., Seong M.H., Shim Y.K., Lee H.S., Han J.H., Shin K.S., et al. Extended spectrum-β-lactamase or carbapenemase producing bacteria isolated from patients with acute cholangitis. Clin Endosc 2012, 45:155-160.
18. Huang C.C., Chen Y.S., Toh H.S., Lee Y.L., Liu Y.M., Ho C.M., et al. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010. Int J Antimicrob Agents 2012, 40(Suppl.):S4-S10.
19. Nicasio A.M., Kuti J.L., Nicolau D.P. The current state of multidrug-resistant Gram-negative bacilli in North America. Pharmacotherapy 2008, 28:235-249.
20. Bush K. Bench-to-bedside review: the role of β-lactamases in antibiotic-resistant Gram-negative infections. Crit Care 2010, 14:224.
21. Hawkey P.M. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008, 14(Suppl.1):159-165.
22. Badal R., Lob S., Bouchillon S., Hoban D., Johnson A., Hackel M. Global trends in frequency and susceptibility of extended-spectrum beta-lactamase positive E.coli, K.pneumoniae, and K.oxytoca isolate from intra-abdominal infections since 2005 - the SMART study. Clin Microbiol Infect 2012, 18(s3). Abstract 1179.
23. Kiratisin P., Chongthaleong A., Tan T.Y., Lagamayo E., Roberts S., Garcia J., et al. Comparative invitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. Int J Antimicrob Agents 2012, 39:311-316.
24. Wang H., Chen M. Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn Microbiol Infect Dis 2005, 51:201-208.
25. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
26. Gupta N., Sohanlal T., Soman R., Shetty A., Rodrigues C. The relevance of ESBL producing isolates in patients surgically treated for acute appendicitis. JAssoc Physicians India 2011, 59:293-295.
27. Yang L., Xiao Y.H., Nie Y., Zheng Y.D., Wang J., Yan Q., et al. Impact of misuse of antimicrobial therapies on inpatient costs. Beijing Da Xue Xue Bao 2010, 42:279-283.
28. Cheong H.S., Kang C.I., Wi Y.M., Kim E.S., Lee J.S., Ko K.S., et al. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med 2008, 121:709-714.
29. Welch J.P., Donaldson G.A. The urgency of diagnosis and surgical treatment of acute suppurative cholangitis. Am J Surg 1976, 131:527-532.
30. Saharia P.C., Cameron J.L. Clinical management of acute cholangitis. Surg Gynecol Obstet 1976, 142:369-372.
31. Chang W.T., Lee K.T., Wang S.R., Chuang S.C., Kuo K.K., Chen J.S., et al. Bacteriology and antimicrobial susceptibility in biliary tract disease: an audit of 10-year's experience. Kaohsiung J Med Sci 2002, 18:221-228.
32. Maluenda F., Csendes A., Burdiles P., Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 1989, 36:132-135.
33. Csendes A., Mitru N., Maluenda F., Diaz J.C., Burdiles P., Csendes P., et al. Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis. Hepatogastroenterology 1996, 43:800-806.
34. Gomi H., Solomkin J.S., Takada T., Strasberg S.M., Pitt H.A., Yoshida M., et al. TG13 antimicrobial therapy for acute cholangitis and cholecystitis. JHepatobiliary Pancreat Sci 2013, 20:60-70.
35. Kiriyama S., Takada T., Strasberg S.M., Solomkin J.S., Mayumi T., Pitt H.A., et al. TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). JHepatobiliary Pancreat Sci 2013, 20:24-34.
36. Nielsen M.L., Justesen T. Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol 1976, 11:437-446.
37. World Health Organization, South East Asia Regional Office Regional strategy on prevention and containment of antimicrobial resistance, 2010-2015 2010, Available from:, [accessed 20.10.12]. http://www.searo.who.int/LinkFiles/BCT_hlm-407.pdf.
38. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.